Merck, Hadassah launch collaboration to use RNA-based therapeutics to fight cancer
Pharmaceutical company Merck and Hadassah University Hospital in Jerusalem launched CanceRNA, which aims to use messenger-RNA technology to treat cancer.
Regine Shevach, Head of Merck’s Innovative Technologies Enablement Center in Israel.(photo credit: Marc Israel Sellem/Jerusalem Post)ByJERUSALEM POST STAFFUpdated:
